| CRIS Snapshot | |
|---|---|
| Curis, Inc., a biotechnology company, is dedicated to the discovery and development of drug candidates for the treatment of human cancers in the United States. The company is headquartered in Lexington, Massachusetts. | |
| VALUATION DATA | |
| Market Capitalization | $87,527,000 | Price to Sales | 1.00 |
| Earnings per Share | $-8.9600 |
| PE Ratio | None |
| PRICE DATA | |
| Most Recent Close | $15.0100 |
| 52 Week High | $8.99 |
| 52 Week Low | $4.579 |
| 50-Day Moving Average | $3.644 |
| 200-Day Moving Average | $-0.809 |
| All data are from Alpha Vantage as of today. For more infomation on CRIS see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search